Skip to main content

Table. 3 Effect of menopausal hormone therapy on ambulatory blood pressure measures

From: Effects of menopausal hormone therapy on ambulatory blood pressure and arterial stiffness in postmenopausal Korean women with grade 1 hypertension: a randomized, placebo-controlled trial

 

Placebo (n = 16)

ET (n = 18)

EPT (n = 17)

Baseline 

12 weeks

Change from baseline

Baseline 

12 weeks

Change from baseline

Baseline 

12 weeks

Change from baseline

Daytime measurement

SBP

147.9 ± 14.3

146.9 ± 11.0

-0.9 ± 12.5

148.0 ± 14.5

146.7 ± 20.0

-1.3 ± 14.2

150.0 ± 11.6

148.5 ± 11.6

-1.4 ± 9.5

DBP

92.8 ± 9.4

91.0 ± 10.6

-2.3 ± 8.7

93.5 ± 9.9

93.8 ± 11.4

0.3 ± 7.1

94.5 ± 10.4

93.3 ± 10.1

-1.2 ± 6.1

HR

72.8 ± 6.8

72.0 ± 7.4

0.1 ± 6.4

73.7 ± 6.3

72.2 ± 7.0

-1.5 ± 6.3

76.6 ± 7.8

74.1 ± 7.4

-2.5 ± 5.7 c

BP loada

SBP

77.0 ± 26.0

74.1 ± 25.5

-2.4 ± 28.2

73.6 ± 26.8

65.8 ± 31.2

-7.8 ± 29.0

77.4 ± 22.8

75.2 ± 20.5

-2.2 ± 16.8

DBP

74.3 ± 25.5

66.2 ± 30.9

-10.5 ± 23.7

66.3 ± 23.6

66.6 ± 27.9

0.2 ± 24.6

71.2 ± 27.2

69.8 ± 31.0

-1.4 ± 10.5

Nighttime measurement

SBP

139.9 ± 16.8

136.4 ± 12.6

-3.7 ± 12.4

135.1 ± 13.6

135.9 ± 17.3

0.8 ± 15.9

145.2 ± 12.1

143.9 ± 12.6

-1.3 ± 10.7

DBP

85.3 ± 11.5

82.4 ± 9.4

-3.2 ± 7.8

83.5 ± 11.3

82.1 ± 9.8

-1.4 ± 8.8

89.1 ± 10.0

87.7 ± 10.0

-1.4 ± 4.3

HR

64.0 ± 6.4

62.2 ± 6.6

-1.2 ± 7.8

61.4 ± 6.3

61.6 ± 4.9

0.2 ± 3.4

66.2 ± 6.6

62.7 ± 5.9

-3.5 ± 7.1

BP loada

SBP

79.1 ± 25.9

77.8 ± 28.5

-2.2 ± 32.1

70.7 ± 28.3

67.2 ± 31.8

-3.5 ± 40.4

89.4 ± 17.8

82.3 ± 26.1

-7.1 ± 21.1

DBP

59.9 ± 27.9

49.4 ± 32.6

-10.8 ± 28.3

56.3 ± 35.3

51.8 ± 34.6

-4.5 ± 39.3

67.3 ± 33.4

61.4 ± 37.9

-5.9 ± 24.3

Night dipb

SBP

-5.3 ± 7.4

-7.8 ± 7.0

-2.7 ± 6.3

-8.3 ± 8.9

-7.1 ± 4.1

1.2 ± 8.2

-2.9 ± 7.9

-3.0 ± 6.9

-0.1 ± 5.2

DBP

-8.0 ± 7.9

-9.6 ± 8.0

-1.4 ± 7.5

-10.3 ± 10.8

-12.0 ± 8.7

-1.7 ± 10.2

-5.4 ± 7.6

-5.8 ± 7.6

-0.4 ± 5.0

24-hour measurement

SBP

146.0 ± 14.1

144.4 ± 10.5

-1.5 ± 11.7

144.8 ± 13.0

143.8 ± 19.2

-1.0 ± 13.4

148.8 ± 10.6

147.3 ± 10.9

-1.5 ± 9.3

DBP

91.0 ± 9.4

89.0 ± 9.9

-2.5 ± 7.9

91.2 ± 9.3

90.8 ± 10.4

-0.3 ± 6.1

93.2 ± 9.7

91.9 ± 9.5

-1.3 ± 5.4

  1. Data are presented as means ± standard deviations
  2. ET estrogen therapy, EPT estrogen + progestogen therapy, SBP systolic blood pressure (mmHg), DBP diastolic blood pressure (mmHg), HR heart rate (bpm), BP blood pressure
  3. a proportion (%) of BP higher than the predefined cutoff level (135/85 mmHg for the daytime and 130/80 mmHg for the nighttime)
  4. bBP difference (mmHg) between the daytime and nighttime
  5. cP-value for within-group difference between baseline and 12 weeks of treatment < 0.05, by the signed-rank test